Pharmaceutical Executive-12-13-2006

Studies show pharma has succeeded at raising disease awareness. Brand loyalty, though, has suffered.

With time ticking on Lipitor's patent, Pfizer is pulling out the stops to make the best of what valuable time it has left.

Recent drug trials, and marketing efforts in Europe, for Acomplia indicate that Sanofi-Aventis may be seeking a life-threatening indication for its much-hyped weight-loss drug.